Nature Reviews Cardiology

Papers
(The H4-Index of Nature Reviews Cardiology is 72. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
LIPC variant in combined hypocholesterolaemia783
Antibody treatment to deplete transthyretin amyloid deposits in the heart502
Sacubitril–valsartan shows benefit in heart failure with ejection fraction of >40%394
Intravascular imaging improves outcomes351
Bariatric metabolic surgery more effective than GLP1R agonists in preventing congestive HF323
Travelling with heart failure: risk assessment and practical recommendations303
Aggregation of big tau disrupts microtubules and causes diastolic dysfunction300
Genetics and mechanisms of thoracic aortic disease293
Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults290
Accelerated reduction in global cardiovascular disease is essential to achieve the Sustainable Development Goals288
Screening for Helicobacter pylori infection in patients with cardiovascular and gastrointestinal disease284
Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications244
Takotsubo syndrome: pathophysiological insights and innovations in patient care244
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective239
Alternative defibrillation strategies improve outcomes234
Electron microscopy of cardiac 3D nanodynamics: form, function, future228
Maternal cardiovascular disorders before and during pregnancy and offspring cardiovascular risk across the life course227
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice225
Detection of subclinical hypertrophic cardiomyopathy206
Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale204
Think Aorta: aortic dissection awareness and perspectives from the patient202
Defining iron deficiency in patients with heart failure198
Hallmarks of cardiovascular ageing194
Neuromodulation reduces inflammation in HFpEF189
A fatty acid from mother’s milk drives cardiomyocyte maturation in newborn mice183
CSDE1 regulates LDL receptor levels178
Preparticipation screening reduces SCD in young athletes168
Graded exercise therapy should not be recommended for patients with post-exertional malaise167
Increased degradation of desmosomal proteins in ACM165
LDL-cholesterol lowering with obicetrapib165
No benefit of apoA-I infusion after myocardial infarction160
Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular risk158
Catheter ablation improves outcomes in patients with AF and end-stage HF157
Decongestion in heart failure: medical and device therapies157
Extracellular matrix in vascular homeostasis and disease146
Colchicine in acute coronary syndromes: the present and the possible future143
The oral microbiome in the pathophysiology of cardiovascular disease135
Targeting immune cell recruitment in atherosclerosis123
Tailored therapeutics for cardiomyopathies122
Prevention of atherosclerosis from childhood121
Reactive oxygen species in hypertension120
Treatment of mild chronic hypertension in pregnancy reduces pre-eclampsia risk116
Donor macrophages influence rejection of transplanted hearts112
Modelling pre-eclampsia and its cardiovascular effects111
Reply to ‘Graded exercise therapy should not be recommended for patients with post-exertional malaise’110
Unlocking excellence in health care: the power of inclusive and sensitive language in medicine103
Cardiac sarcomere turnover by unidirectional replacement of proteins103
RNA interference lowers triglyceride levels103
Bempedoic acid prevents cardiovascular events in statin-intolerant patients102
Promising novel siRNA for the treatment of hypertension101
Evidence does not support the reduction of added sugar intake from all food sources101
Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials97
Semaglutide is beneficial in patients with HFpEF and obesity90
Global epidemiology of heart failure89
Single-cell profiles of CHD and CM87
An epigenome editing approach induces durable silencing of Pcsk987
BP management with a village-doctor-led strategy86
Computational modelling of cardiovascular pathophysiology to risk stratify commercial spaceflight85
Novel factor XIa inhibitor reduces bleeding compared with apixaban in atrial fibrillation83
Simvastatin protects against endothelial dysfunction via epigenetic mechanisms80
Author Correction: The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis79
Development of a miniature, bioresorbable, light-activated pacemaker79
The gut metabolite imidazole propionate is a potential biomarker of and therapeutic target for atherosclerosis79
Heart transplantation: advances in expanding the donor pool and xenotransplantation77
The role of the molecular autopsy in sudden cardiac death in young individuals77
Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target77
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology76
Low alcohol intake might lower CVD risk by reducing stress-related brain activity74
New insights into dietary cholesterol absorption74
CNR1 antagonism attenuates cannabis-induced atherosclerosis74
Efferocytosis in atherosclerosis74
Fibroblast-like cells promote plaque stability in response to anti-IL-1β therapy74
Cardiovascular benefits of fermented foods and beverages: still up for debate72
0.16921782493591